TrialContemporary clinical trials2016

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Robert J Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.